Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors

Drug and Alcohol Dependence

Volumn 89, Issue 2-3, 2007, Pages 234-243

  Neaigus, Alan ^a,b   Gyarmathy, V Anna ^a,c   Miller, Maureen ^b   Frajzyngier, Vera ^a   Zhao, Mingfang ^a   Friedman, Samuel R ^a,c   Jarlais, Don C Des ^d  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b Columbia University ^*  (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Drug injectors; HBV; HCV; HIV; Injecting risk; Sexual risk

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; EARLY INTERVENTION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INJECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK; SEROPREVALENCE; SEX DIFFERENCE; SEXUALITY; VACCINATION;

ADOLESCENT; ADULT; COMORBIDITY; FEMALE; HEALTH SURVEYS; HEPATITIS B; HEPATITIS C; HIV SEROPREVALENCE; HUMANS; MALE; NEW YORK CITY; PROSTITUTION; SEROEPIDEMIOLOGIC STUDIES; SEXUAL PARTNERS; STATISTICS; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX; URBAN POPULATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 34248525496     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.01.003     Document Type: Article

References (47)

1. Bennett G.A., Velleman R.D., Barter G., and Bradbury C. Gender differences in sharing injecting equipment by drug users in England. AIDS Care 12 (2000) 77-87
2. Chaisson R.E., Bacchetti P., Osmond D., Brodie B., Sande M.A., and Moss A.R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261 (1989) 561-565
3. Des Jarlais D.C., Friedman S.R., Perlis T.E., Chapman T.F., Sotheran J.L., Paone D., Monterroso E., and Neaigus A. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J. Acquir. Immune Defic. Syndr. 20 (1999) 67-72
4. Des Jarlais D.C., Perlis T., Friedman S.R., Chapman T., Kwok J., Rockwell R., Paone D., Milliken J., and Monterroso E. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am. J. Public Health 90 (2000) 1112-1116
5. Des Jarlais D.C., Diaz T., Perlis T., Vlahov D., Maslow C., Latka M., Rockwell R., Edwards V., Friedman S.R., Monterroso E., Williams I., and Garfein R.S. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am. J. Epidemiol. 157 (2003) 467-471
6. Doherty M.C., Garfein R.S., Monterroso E., Latkin C., and Vlahov D. Gender differences in the initiation of injection drug use among young adults. J. Urban Health 77 (2000) 396-414
7. Emmanuelli J., and Desenclos J.C. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction 100 (2005) 1690-1700
8. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe, Mid-Year Report 2003 (2003), Institute de Veille Sanitaire, Saint Maurice, France
9. Evans J.L., Hahn J.A., Page-Shafer K., Lum P.J., Stein E.S., Davidson P.J., and Moss A.R. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J. Urban Health 80 (2003) 137-146
10. Frajzyngier V.M., Neaigus A., Gyarmathy V.A., Miller M., and Friedman S.R. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend 89 (2007) 145-152
11. Friedman S.R., Des Jarlais D.C., Neaigus A., Abdul-Quader A., Sotheran J.L., Sufian M., Tross S., and Goldsmith D. AIDS and the new drug injector. Nature 339 (1989) 333-334
12. Friedman S.R., Neaigus A., Jose B., Curtis R., Goldstein M.F., Ildefonso G., Rothenberg R.B., and Des Jarlais D.C. Sociometric risk networks and risk for HIV infection. Am. J. Public Health 87 (1997) 1289-1296
13. Friedman S.R., Curtis R., Neaigus A., Jose B., and Des Jarlais D.C. Social Networks, Drug Injectors' Lives, and HIV (1999), Plenum Press, New York
14. Friedman S.R., Chapman T.F., Perlis T.E., Rockwell R., Paone D., Sotheran J.L., and Des Jarlais D.C. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996. J. Acquir. Immune Defic. Syndr. 22 (1999) 83-91
15. Friedman S.R., Ompad D.C., Maslow C., Young R., Case P., Hudson S.M., Diaz T., Morse E., Bailey S., Des Jarlais D.C., Perlis T., Hollibaugh A., and Garfein R.S. HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am. J. Public Health 93 (2003) 902-906
16. Gambotti L., Batisse D., Colin-de-Verdiere N., Aroque-Astagneau E., Desenclos J.C., Dominguez S., Dupont C., Duval X., Gervais A., Ghosn J., Larsen C., Pol S., Serpaggi J., Simon A., Valantin M.A., and Velter A. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Eur. Surveill. 10 (2005) 115-117
17. Garfein R.S., Vlahov D., Galai N., Doherty M.C., and Nelson K.E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Public Health 86 (1996) 655-661
18. Ghosn J., Pierre-Francois S., Thibault V., Duvivier C., Tubiana R., Simon A., Valantin M.A., Dominguez S., Caumes E., and Katlama C. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med. 5 (2004) 303-306
19. Gotz H., van Doornum G., Niesters H., den Hollander J., Thio H., and de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men-results from contact tracing and public health implications. AIDS 19 (2005) 969-974
20. Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., and Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 91 (2001) 42-46
21. Hahn J.A., Page-Shafer K., Lum P.J., Ochoa K., and Moss A.R. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 34 (2001) 180-187
22. Heckathorn D.D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc. Problems 44 (1997) 174-199
23. Holmberg S.D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 86 (1996) 642-654
24. Ippolito G., Puro V., Heptonstall J., Jagger J., De C.G., and Petrosillo N. Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin. Infect. Dis. 28 (1999) 365-383
25. Kral A.H., Bluthenthal R.N., Lorvick J., Gee L., Bacchetti P., and Edlin B.R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357 (2001) 1397-1401
26. Miller M., and Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care 14 (2002) 801-813
27. Ndimbie O.K., Kingsley L.A., Nedjar S., and Rinaldo C.R. Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin. Med. 72 (1996) 213-216
28. Neaigus A., Sufian M., Friedman S.R., Goldsmith D.S., Stepherson B., Mota P., Pascal J., and Des Jarlais D.C. Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ. Prev. 2 (1990) 253-271
29. Neaigus A., Friedman S.R., Curtis R., Des Jarlais D.C., Furst R.T., Jose B., Mota P., Stepherson B., Sufian M., Ward T., and Wright J.W. The relevance of drug injectors' social networks and risk networks for understanding and preventing HIV infection. Soc. Sci. Med. 38 (1994) 67-78
30. Neaigus A., Friedman S.R., Goldstein M.F., Ildefonso G., Curtis R., and Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Res. Monogr. 151 (1995) 20-37
31. Neaigus A., Friedman S.R., Jose B., Goldstein M.F., Curtis R., Ildefonso G., and Des Jarlais D.C. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J. Acquir. Immune Defic. Syndr. 11 (1996) 499-509
32. Neaigus A., Gyarmathy V.A., Miller M., Frajzyngier V.M., Friedman S.R., and Des Jarlais D.C. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J. Acquir. Immune Defic. Syndr. 41 (2006) 493-503
33. Nelson K.E., Vlahov D., Solomon L., Cohn S., and Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch. Intern. Med. 155 (1995) 1305-1311
34. Puro V., De C.G., Scognamiglio P., Porcasi R., and Ippolito G. Risk of HIV and other blood-borne infections in the cardiac setting: patient-to-provider and provider-to-patient transmission. Ann. N. Y. Acad. Sci. 946 (2001) 291-309
35. Robles R.R., Colón H.M., Sahai H., Matos T.D., Marrero C.A., and Reyes J.C. Behavioral risk factors and HIV prevalence among intravenous drug users in Puerto Rico. Am. J. Epidemiol. 135 (1992) 531-540
36. Rooney G., and Gilson R.J. Sexual transmission of hepatitis C virus infection. Sex Transm. Infect. 74 (1998) 399-404
37. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 36 (2002) S35-S46
38. Semaan S., Des Jarlais D.C., Sogolow E., Johnson W.D., Hedges L.V., Ramirez G., Flores S.A., Norman L., Sweat M.D., and Needle R. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J. Acquir. Immune Defic. Syndr. 30 Suppl. 1 (2002)
39. Shafer K.P., Hahn J.A., Lum P.J., Ochoa K., Graves A., and Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J. Acquir. Immune Defic. Syndr. 31 (2002) 422-431
40. Sifaneck S.J., and Neaigus A. The ethnographic accessing, sampling and screening of hidden populations: heroin sniffers in New York City. Addict. Res. Theory 9 (2001) 519-543
41. Solomon L., Astemborski J., Warren D., Munoz A., Cohn S., Vlahov D., and Nelson K.E. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am. J. Epidemiol. 137 (1993) 892-898
42. Strathdee S.A., Patrick D.M., Archibald C.P., Ofner M., Cornelisse P.G., Rekart M., Schechter M.T., and O'Shaughnessy M.V. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction 92 (1997) 1339-1347
43. Strathdee S.A., Galai N., Safaiean M., Celentano D.D., Vlahov D., Johnson L., and Nelson K.E. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch. Intern. Med. 161 (2001) 1281-1288
44. Strathdee S.A., and Sherman S.G. The role of sexual transmission of HIV infection among injection and non-injection drug users. J. Urban Health 80 (2003) 7-14
45. Thomas D.L., Cannon R.O., Shapiro C.N., Hook III E.W., Alter M.J., and Quinn T.C. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J. Infect. Dis. 169 (1994) 990-995
46. Watters J., and Biernacki P. Targeted sampling: options for the study of hidden populations. Soc. Prob. 6 (1989) 416-430
47. Wejstal R. Sexual transmission of hepatitis C virus. J. Hepatol. 31 Suppl. 1 (1999) 92-95